Guest post by Keith C. Owens, Partner  at Fox Rothschild LLP Like most American businesses, COVID-19 has placed a heavy strain on cannabis-related businesses, which were already struggling due...

TORONTO, November 01, 2019–(BUSINESS WIRE)–DionyMed Brands Inc. (“DionyMed”) (CSE: DYME; OTCQB: DYMEF), and together with its direct and indirect subsidiaries (the “Company”), a multi-state cannabis brands, direct-to-consumer and distribution...

TORONTO, OCTOBER 29, 2019–(BUSINESS WIRE)– DionyMed Brands Inc. (“DionyMed” or the “Company“) (CSE: DYME; OTCQB: DYMEF), a multi-state cannabis brands, direct-to-consumer and distribution platform, previously announced that GLAS USA...